Terms: = Uterine cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Prognosis
22 results:
1. Gestational choriocarcinoma.
Bogani G; Ray-Coquard I; Mutch D; Vergote I; Ramirez PT; Prat J; Concin N; Ngoi NYL; Coleman RL; Enomoto T; Takehara K; Denys H; Lorusso D; Takano M; Sagae S; Wimberger P; Segev Y; Kim SI; Kim JW; Herrera F; Mariani A; Brooks RA; Tan D; Paolini B; Chiappa V; Longo M; Raspagliesi F; Benedetti Panici P; Di Donato V; Caruso G; Colombo N; Pignata S; Zannoni G; Scambia G; Monk BJ
Int J Gynecol Cancer; 2023 Oct; 33(10):1504-1514. PubMed ID: 37758451
[TBL] [Abstract] [Full Text] [Related]
2. Bioinformatic Analysis of miR-200b/429 and Hub Gene Network in Cervical cancer.
Shukla V; Mallya S; Adiga D; Sriharikrishnaa S; Chakrabarty S; Kabekkodu SP
Biochem Genet; 2023 Oct; 61(5):1898-1916. PubMed ID: 36879084
[TBL] [Abstract] [Full Text] [Related]
3. Significance of HER2 and vegfr2 in Early-stage Endometrial cancer.
An HJ; Song DH; Kim YM; Jo HC; Baek JC; Park JE
In Vivo; 2022; 36(2):723-730. PubMed ID: 35241527
[TBL] [Abstract] [Full Text] [Related]
4. CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
Coquan E; Brachet PE; Licaj I; Leconte A; Castera M; Lequesne J; Meriaux E; Bonnet I; Lelaidier A; Clarisse B; Joly F
BMC Cancer; 2021 Sep; 21(1):1054. PubMed ID: 34563169
[TBL] [Abstract] [Full Text] [Related]
5. Changes in the Expression Profile of VEGF-A, VEGF-B, vegfr-1, vegfr-2 in Different Grades of Endometrial cancer.
Dziobek K; Opławski M; Grabarek BO; Zmarzły N; Tomala B; Halski T; Leśniak E; Januszyk K; Brus R; Kiełbasiński R; Boroń D
Curr Pharm Biotechnol; 2019; 20(11):955-963. PubMed ID: 31322068
[TBL] [Abstract] [Full Text] [Related]
6. The role of lncRNAs in signaling pathway implicated in CC.
Yang M; Wang M; Li X; Xie Y; Xia X; Tian J; Zhang K; Tang A
J Cell Biochem; 2019 Mar; 120(3):2703-2712. PubMed ID: 30552693
[TBL] [Abstract] [Full Text] [Related]
7. Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel.
Qiu H; Li J; Liu Q; Tang M; Wang Y
Cell Cycle; 2018; 17(10):1235-1244. PubMed ID: 29886786
[TBL] [Abstract] [Full Text] [Related]
8. Synchronous Cervical Minimal Deviation Adenocarcinoma, Gastric Type Adenocarcinoma and Lobular Endocervical Glandular Hyperplasia Along with STIL in Peutz-Jeghers Syndrome: Eliciting Oncogenesis Pathways.
Neyaz A; Husain N; Deodhar M; Khurana R; Shukla S; Arora A
Turk Patoloji Derg; 2019; 35(3):247-253. PubMed ID: 28832082
[TBL] [Abstract] [Full Text] [Related]
9. Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer.
Punt S; Houwing-Duistermaat JJ; Schulkens IA; Thijssen VL; Osse EM; de Kroon CD; Griffioen AW; Fleuren GJ; Gorter A; Jordanova ES
Mol Cancer; 2015 Mar; 14():71. PubMed ID: 25889974
[TBL] [Abstract] [Full Text] [Related]
10. Expression profiling and significance of VEGF-A, vegfr2, vegfr3 and related proteins in endometrial carcinoma.
Wang J; Taylor A; Showeil R; Trivedi P; Horimoto Y; Bagwan I; Ewington L; Lam EW; El-Bahrawy MA
Cytokine; 2014 Aug; 68(2):94-100. PubMed ID: 24845798
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic significance of angiogenic factors in uterine cervical cancer.
Landt S; Wehling M; Heidecke H; Jeschke S; Korlach S; Stöblen F; Schmid P; Blohmer JU; Lichtenegger W; Sehouli J; Kümmel S
Anticancer Res; 2011 Aug; 31(8):2589-95. PubMed ID: 21778309
[TBL] [Abstract] [Full Text] [Related]
12. Molecular characterization of EGFR, PDGFRA and vegfr2 in cervical adenosquamous carcinoma.
Longatto-Filho A; Pinheiro C; Martinho O; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Baltazar F; Reis RM
BMC Cancer; 2009 Jun; 9():212. PubMed ID: 19563658
[TBL] [Abstract] [Full Text] [Related]
13. Angiogenesis and expression of angiogenic agents in uterine and ovarian carcinosarcomas.
Näyhä V; Stenbäck F
APMIS; 2008 Feb; 116(2):107-17. PubMed ID: 18321361
[TBL] [Abstract] [Full Text] [Related]
14. Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/vegfr2(kdr) pathway and prognosis.
Giatromanolaki A; Sivridis E; Gatter KC; Turley H; Harris AL; Koukourakis MI;
Gynecol Oncol; 2006 Dec; 103(3):912-8. PubMed ID: 16837029
[TBL] [Abstract] [Full Text] [Related]
15. Phosphorylated kdr expression in endometrial cancer cells relates to HIF1alpha/VEGF pathway and unfavourable prognosis.
Giatromanolaki A; Koukourakis MI; Turley H; Sivridis E; Harris AL; Gatter KC;
Mod Pathol; 2006 May; 19(5):701-7. PubMed ID: 16557278
[TBL] [Abstract] [Full Text] [Related]
16. VEGF and its receptors (flt-1 and kdr/flk-1) as prognostic indicators in endometrial carcinoma.
Talvensaari-Mattila A; Soini Y; Santala M
Tumour Biol; 2005; 26(2):81-7. PubMed ID: 15867479
[TBL] [Abstract] [Full Text] [Related]
17. [Expression and significance about VEGF, kdr, MMP-1, and transcription factor Ets-1 in human cervical carcinoma].
Xu FL; Li YL; Wang ZD; Feng YJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):396-400. PubMed ID: 12974081
[TBL] [Abstract] [Full Text] [Related]
18. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis.
Schoppmann SF; Birner P; Stöckl J; Kalt R; Ullrich R; Caucig C; Kriehuber E; Nagy K; Alitalo K; Kerjaschki D
Am J Pathol; 2002 Sep; 161(3):947-56. PubMed ID: 12213723
[TBL] [Abstract] [Full Text] [Related]
19. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract] [Full Text] [Related]
20. Angiogenesis and endometrial cancer.
Sivridis E
Anticancer Res; 2001; 21(6B):4383-8. PubMed ID: 11908694
[TBL] [Abstract] [Full Text] [Related]
[Next]
